菌体封装和输送技术:一种治疗耐药病原微生物的策略
Yang Yue1, Zhenbo Xu1,2, Thanapop Soteyome3
1School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.
Pharmaceuticals (Basel, Switzerland)
|November 27, 2025
概括
抗菌素耐药性 (AMR) 是一个全球性的健康危机. 封装菌体 (菌体) 疗法为抗生素提供了一个有希望的替代品,克服了治疗细菌感染的无活化和耐药性等挑战.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 公共卫生 公共卫生
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球严重的健康威胁,导致治疗失败和高死亡率.
- 传统的抗生素正在对快速传播的耐药细菌失去有效性.
- 菌体 (菌体) 疗法正在成为一种新型的抗菌战略.
研究的目的:
- 审查对主要病原体的菌体治疗研究,包括沙门氏菌, Pseudomonas aeruginosa,金黄色葡萄球菌, Escherichia coli 和 Listeria monocytogenes.
- 总结了菌体研究和开发的最新进展.
- 详细说明封装菌体技术的应用,以提高输送和疗效.
主要方法:
- 对菌体疗法和封装技术的当前文献的综述.
- 对专注于特定细菌病原体及其菌体治疗的研究进行分析.
- 检查先进的封装方法,如电纤维,脂质体和纳米粒子.
主要成果:
- 菌体疗法,特别是尾酒和工程菌体,显示出增强的宽谱活性和对病原细菌的效率.
- 封装技术有效地保护菌体活动免受失活 (胃酸,紫外线,压力) 并实现有针对性的输送.
- 研究表明,封装的菌体有潜力对抗沙门氏菌,P. aeruginosa,S. aureus,大肠杆菌和L. monocytogenes.
结论:
- 封装菌体技术为克服传统菌体治疗的局限性提供了一个可行的解决方案.
- 这种方法增强了菌体稳定性,受控释放和向输送,将其定位为下一代抗生素替代品.
- 封装菌体的进一步开发和应用对于有效打击AMR至关重要.
相关概念视频
Lytic Cycle of Bacteriophages
77.3K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.3K
DNA Bacteriophages
765
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
765
Microorganisms in Medicine and Therapeutics
920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Lysogenic Cycle of Bacteriophages
67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Viral Replication: Lysogenic Cycle
1.3K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.3K


